These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3780819)

  • 1. Inducing effect of feprazone on hepatic drug-metabolizing enzymes in man.
    Morita K; Shibata H; Ono T; Shimakawa H
    Eur J Clin Pharmacol; 1986; 31(1):117-8. PubMed ID: 3780819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feprazone: an inducer of the P450 II B family of proteins in the rat.
    Smith JN; Ayrton AD; Chown J; Lewis DF; Ioannides C
    J Biochem Toxicol; 1990; 5(1):9-12. PubMed ID: 2402005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased 6-hydroxycortisol excretion in pregnant women: implication of drug-metabolizing enzyme induction.
    Ohkita C; Goto M
    DICP; 1990 Sep; 24(9):814-6. PubMed ID: 2260334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme induction by enflurane in man.
    Berman ML; Green OC; Calverley RK; Smith NT; Eger EI
    Anesthesiology; 1976 Jun; 44(6):496-500. PubMed ID: 1275317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of feprazone and phenylbutazone on testosterone hydroxylations in mouse hepatic microsomes.
    Morita K; Hayashi Y; Ono T; Shimakawa H
    Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):214-20. PubMed ID: 3698130
    [No Abstract]   [Full Text] [Related]  

  • 6. 6 beta-hydroxycortisol in random urine samples as an indicator of enzyme induction.
    Saenger P
    Clin Pharmacol Ther; 1983 Dec; 34(6):818-21. PubMed ID: 6641098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects.
    Meloni T; Forteleoni G; Serra M; Daniotti S; Negri L; Giuntini P; Canepa L; Gaetani GF
    J Clin Pharmacol; 1982; 22(8-9):418-20. PubMed ID: 7130431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary 6beta-hydroxycortisol/17-hydroxycorticosteroids ratio as a measure of hepatic CYP3A4 capacity after enzyme induction.
    Konishi H; Tanaka K; Minouchi T; Yamaji A
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):335-7. PubMed ID: 15298747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of phenobarbitone on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithrix jacchus).
    Challiner MR; Park BK; Odum J; Orton TC; Parker GL
    Biochem Pharmacol; 1980 Dec; 29(24):3319-24. PubMed ID: 6971098
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic injury following feprazone therapy.
    Wiggins J; Scott DL
    Rheumatol Rehabil; 1981 Feb; 20(1):44-5. PubMed ID: 6452677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disposition of feprazone and its hydroxylated metabolite in human volunteers.
    Berry D; Parke DV
    Xenobiotica; 1988 Jul; 18(7):857-68. PubMed ID: 3176523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.
    Fletcher MR; Loebl W; Scott JT
    Ann Rheum Dis; 1975 Apr; 34(2):190-4. PubMed ID: 1094965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urinary 6 beta-hydroxycortisol excretion in man on inducers and inhibitors of the hepatic mixed function oxidase.
    Desager JP; Dumont E; Harvengt C
    Pharmacol Ther; 1987; 33(1):197-9. PubMed ID: 3628474
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug.
    Koyama T; Izawa Y; Wada H; Makita T; Hashimoto Y; Enomoto M
    Toxicol Appl Pharmacol; 1982 Jun; 64(2):255-70. PubMed ID: 7123554
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind trial of feprazone and phenylbutazone in acute gout.
    Reardon JA; Stockman A; Darlington LG; Scott JT
    Curr Med Res Opin; 1980; 6(7):445-8. PubMed ID: 6988172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man.
    Ohnhaus EE; Breckenridge AM; Park BK
    Eur J Clin Pharmacol; 1989; 36(1):39-46. PubMed ID: 2917586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal blood loss on phenylbutazone and feprazone.
    Macfarlane JD; Maisey MN; Grahame R; Burry HC
    Rheumatol Rehabil; 1976 May; 15(2):108-11. PubMed ID: 132693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal administration of feprazone in healthy volunteers.
    Ferrari P; Montanari C; Sala P; Vidi A
    Br J Clin Pharmacol; 1976 Apr; 3(2):339-40. PubMed ID: 973970
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolites of feprazone in man.
    Yamaguchi H; Kubo J; Sekine K; Naruchi T; Hashimoto Y; Kato R
    Drug Metab Dispos; 1979; 7(5):340-4. PubMed ID: 40778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme induction by phenobarbitone and vitamin K1 disposition in man.
    Park BK; Wilson AC; Kaatz G; Ohnhaus EE
    Br J Clin Pharmacol; 1984 Jul; 18(1):94-7. PubMed ID: 6743493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.